Aarey Drugs & Pharmaceuticals Limited (NSE: AAREYDRUGS), ISIN INE198H01019 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AAREYDRUGS last traded at ₹75.97 (-2.00%), with a 52-week range of ₹50.40 to ₹100.00 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 37.71%, FIIs 4.18%, DIIs 1.62%, mutual funds 0.00%.
EquiSense Score (ECS): 55/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.